1. Home
  2. FLR vs GKOS Comparison

FLR vs GKOS Comparison

Compare FLR & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLR
  • GKOS
  • Stock Information
  • Founded
  • FLR 1912
  • GKOS 1998
  • Country
  • FLR United States
  • GKOS United States
  • Employees
  • FLR N/A
  • GKOS N/A
  • Industry
  • FLR Military/Government/Technical
  • GKOS Medical/Dental Instruments
  • Sector
  • FLR Industrials
  • GKOS Health Care
  • Exchange
  • FLR Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • FLR 8.1B
  • GKOS 5.7B
  • IPO Year
  • FLR N/A
  • GKOS 2015
  • Fundamental
  • Price
  • FLR $51.29
  • GKOS $104.15
  • Analyst Decision
  • FLR Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • FLR 7
  • GKOS 13
  • Target Price
  • FLR $47.43
  • GKOS $135.15
  • AVG Volume (30 Days)
  • FLR 4.7M
  • GKOS 939.6K
  • Earning Date
  • FLR 08-01-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • FLR N/A
  • GKOS N/A
  • EPS Growth
  • FLR 563.49
  • GKOS N/A
  • EPS
  • FLR 10.64
  • GKOS N/A
  • Revenue
  • FLR $16,563,000,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • FLR $10.92
  • GKOS $27.88
  • Revenue Next Year
  • FLR $6.29
  • GKOS $27.60
  • P/E Ratio
  • FLR $4.83
  • GKOS N/A
  • Revenue Growth
  • FLR 7.16
  • GKOS 23.92
  • 52 Week Low
  • FLR $29.20
  • GKOS $77.10
  • 52 Week High
  • FLR $60.10
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • FLR 68.62
  • GKOS 58.72
  • Support Level
  • FLR $48.12
  • GKOS $96.04
  • Resistance Level
  • FLR $51.77
  • GKOS $101.32
  • Average True Range (ATR)
  • FLR 1.98
  • GKOS 3.48
  • MACD
  • FLR 0.07
  • GKOS 0.29
  • Stochastic Oscillator
  • FLR 95.23
  • GKOS 80.94

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: